Applied Nutrition reported a 43.9% increase in pre-tax profits to £41 million for the fiscal year ending July 31, driven by a 50.9% surge in sales. The company attributed part of this growth to the launch of a product line specifically designed for individuals using GLP-1 weight-loss medications, alongside a 142% rise in sales of its relaunched Critical Whey product. Despite these gains, the firm warned that significantly higher raw material costs for whey protein would limit its ability to raise profit forecasts for the upcoming year. Management stated it would maintain current market expectations rather than increasing guidance due to these cost pressures. The company projects underlying earnings of approximately £49 million and total sales of £205 million for the next fiscal year, citing broad consumer demand for health and wellness products.
Bias read (Center): The article presents standard corporate financial results and management commentary regarding market trends and cost pressures without employing loaded language or taking a partisan stance.




